The Global Synthetic Biology Market 2027-2037 Report Now Available - Reveals Why Scale-Up, Not Lab Results, Is Now The Industry's Binding Constraint
Dublin, Sept. 01, 2026 (GLOBE NEWSWIRE) -- The "The Global Synthetic Biology Market 2027-2037" report has been added to ResearchAndMarkets.com's offering.
Synthetic biology applies engineering principles to living systems, designing and constructing biological parts, devices and organisms that do not occur in nature, or redesigning existing ones for defined purposes. It differs from conventional genetic engineering in both ambition and method. Where genetic engineering introduces limited, targeted modifications to an existing organism, synthetic biology treats biology as a programmable platform, engineered through iterative design-build-test-learn cycles that draw on molecular biology, engineering, computer science and automation. The outputs are correspondingly different: not merely enhanced organism traits, but novel organisms, metabolic pathways and biomolecules.
The field spans a broad technology base. DNA synthesis and assembly, genome engineering, metabolic engineering, protein and enzyme engineering, synthetic genomics and computational design form the core toolset, supported by automated biofoundries, biosensors, robotics and expanding capability in xenobiology and cell-free systems. These tools are deployed across an unusually wide range of end markets - pharmaceuticals and healthcare, bio-based chemicals, bioplastics and biopolymers, biofuels, agriculture, food and nutraceutical ingredients, textiles, packaging, cosmetics, surfactants, construction materials, biocatalysis and bioremediation.
Three structural shifts define the current period. The first is convergence: synthetic biology, industrial enzymes and white biotechnology were historically analysed as separate sectors; they now share the same toolsets, the same customers and increasingly the same balance sheets, making separate segmentation artificial and treating them as one industrial biomanufacturing market more accurate. The second is the elevation of policy from background condition to primary determinant, with regulatory frameworks and industrial strategy in the European Union, United States and Asia now materially shaping where production capacity is built and which products reach market first.
The third, and the most important commercially, is that scale-up remains the binding constraint. Laboratory and bench results reproduce reliably. The transition to commercial fermentation volumes exposes oxygen transfer limits, heat removal constraints, contamination risk, feedstock variability and downstream recovery losses that were invisible at small scale and that routinely destroy process economics. This gap explains the recurring pattern of well-funded platform companies failing between late-stage financing and commercial launch. The consequence is a bifurcating market: companies with production assets, contract manufacturing relationships or access to shared pilot infrastructure are converting technical capability into revenue, while those licensing technology alone remain exposed to the biotechnology funding cycle. Consolidation is expected to continue.
This report provides a comprehensive analysis of the global synthetic biology and biomanufacturing market across the 2027-2037 period, with historical context from 2019. It assesses the technical, commercial and regulatory factors shaping the sector, and segments the market by technology platform, product type, application sector and geography. Coverage extends across the applications in which synthetic biology is being commercialised: biofuels, bio-based chemicals, bioplastics and biopolymers, bioremediation, biocatalysis, food and nutraceutical ingredients, sustainable agriculture, textiles, packaging, healthcare and pharmaceuticals, cosmetics, surfactants and detergents, and construction materials.
The report includes a detailed technology roadmap to 2037, SWOT analysis, assessment of industry challenges and constraints, analysis of the scale-up and pilot infrastructure bottleneck, the regulatory and policy landscape across the European Union, United States and Asia, the industrial biotechnology value chain, the convergence of synthetic biology with industrial enzymes and white biotechnology, and a review of investment activity across the sector. It contains 137 tables, 68 figures and profiles of 327 companies spanning the synthetic biology value chain, from DNA synthesis and biofoundry platforms through fermentation producers, materials companies and end-market brands.
Contents include:
- Executive summary - overview of the global market; difference between synthetic biology and genetic engineering; market size and growth by technology, product type, market and region; major trends and drivers; investments; technology roadmap; convergence of synthetic biology, industrial enzymes and white biotechnology; regulatory and policy landscape; colours of biotechnology; industrial biotechnology value chain Introduction - what is synthetic biology; comparison with conventional processes; applications; advantages; sustainability; synthetic biology for the circular economy Technology analysis - biomanufacturing processes (batch, continuous, fermentation, cell-free, biofilm, microfluidic, photobioreactors, membrane bioreactors, plant and mammalian cell culture, bioprinting); cell factories; metabolic engineering; gene and DNA synthesis; genome engineering (CRISPR, TALENs, ZFNs); protein/enzyme engineering; synthetic genomics; strain construction; smart bioprocessing; chassis organisms; biomimetics; robotics and automation; bioinformatics; xenobiology; biosensors; feedstocks; marine biotechnology Market analysis - trends and drivers; industry challenges; bioeconomy; SWOT; markets across biofuels, bio-based chemicals, bioplastics and biopolymers, bioremediation, biocatalysis, food and nutraceutical ingredients, sustainable agriculture, textiles, packaging, healthcare and pharmaceuticals, cosmetics, surfactants and detergents, and construction materials Global market revenues 2019-2037 by technology, product type, market and region; scale-up and pilot infrastructure; natural molecule drug discovery; future market outlook Company profiles - 327 profiles spanning the synthetic biology value chain Appendix - research methodology and glossary; references
Key Topics Covered:
1 EXECUTIVE SUMMARY
1.1 Overview of the global synthetic biology market
1.2 Difference between synthetic biology and genetic engineering
1.3 Market size and growth projections
1.4 Major trends and drivers
1.5 Investments in synthetic biology
1.6 Technology roadmap
1.7 Technology convergence: synthetic biology, industrial enzymes and white biotechnology
1.8 Regulatory and policy landscape
1.9 Colours of biotechnology
1.10 Industrial biotechnology value chain
2 INTRODUCTION
2.1 What is synthetic biology?
2.2 Comparison with conventional processes
2.3 Applications
2.4 Advantages
2.5 Sustainability
2.6 Synthetic Biology for the Circular Economy
3 TECHNOLOGY ANALYSIS
3.1 Biomanufacturing processes
3.2 Cell factories for biomanufacturing
3.3 Technology Overview
4 MARKET ANALYSIS
4.1 Market trends and drivers
4.2 Industry challenges and constraints
4.3 Synthetic biology in the bioeconomy
4.4 SWOT analysis
4.5 Synthetic biology markets
4.6 Global market revenues 2019-2037
4.7 Scale-up and pilot infrastructure
4.8 Natural molecule drug discovery
4.9 Future Market Outlook
5 COMPANY PROFILES (327 company profiles)
6 APPENDIX
6.1 Research Methodology
6.2 Glossary of Terms
7 REFERENCES
LIST OF TABLES
Table 1. Comparison of synthetic biology and genetic engineering.
Table 2. Global Revenues for Synthetic Biology by Technology, 2019-2037 (Billion USD).
Table 3. Global Revenues for Synthetic Biology by Product Type, 2019-2037 (Billion USD).
Table 4. Global revenues for synthetic biology, by market, 2019-2037 (Billion USD).
Table 5. Global revenues for synthetic biology, by region, 2019-2037 (Billion USD).
Table 6. Major trends and drivers in synthetic biology.
Table 7. Investments in synthetic biology.
Table 8. Phase 1: Consolidation & Cost-Down (2027-2029).
Table 9. Phase 2: Integration & Scale (2030-2032).
Table 10. Phase 3: Transformation & Convergence (2033-2035).
Table 11. Phase 4: Maturation & Optimization (2036-2037).
Table 12. Convergence of synthetic biology, industrial enzymes and white biotechnology.
Table 13. Policy instruments shaping the 2027-2037 market.
Table 14. Differences between synthetic biology and conventional processes.
Table 15. Main application areas for synthetic biology.
Table 16. Advantages of synthetic biology.
Table 17. Key biomanufacturing processes utilized in synthetic biology.
Table 18. Molecules produced through industrial biomanufacturing.
Table 19. Continuous vs batch biomanufacturing
Table 20. Key fermentation parameters in batch vs continuous biomanufacturing processes.
Table 21. Synthetic biology fermentation processes.
Table 22. Cell-free versus cell-based systems
Table 23. Comparison of the biomanufacturing processes in synthetic biology.
Table 24. Major microbial cell factories used in industrial biomanufacturing.
Table 25. Core stages - Design, Build and Test.
Table 26. Key tools and techniques used in metabolic engineering for pathway optimization.
Table 27. Key applications of metabolic engineering.
Table 28. Main DNA synthesis technologies
Table 29. Main gene assembly methods.
Table 30. Key applications of genome engineering.
Table 31. Engineered proteins in industrial applications.
Table 32. Key computational tools and their applications in synthetic biology.
Table 33. Feedstocks for synthetic biology.
Table 34. Products from C1 feedstocks in white biotechnology.
Table 35. C2 Feedstock Products.
Table 36. CO2 derived products via biological conversion-applications, advantages and disadvantages.
Table 37. Production capacities of biorefinery lignin producers.
Table 38. Common starch sources that can be used as feedstocks for producing biochemicals.
Table 39. Biomass processes summary, process description and TRL.
Table 40. Pathways for hydrogen production from biomass.
Table 41. Overview of alginate-description, properties, application and market size.
Table 42. Blue biotechnology companies.
Table 43. Market trends and drivers in synthetic biology.
Table 44. Industry challenges and restraints in synthetic biology.
Table 45. Key markets and applications for synthetic biology.
Table 46. Comparison of biofuels.
Table 47. Categories and examples of solid biofuel.
Table 48. Comparison of biofuels and e-fuels to fossil and electricity.
Table 49. Classification of biomass feedstock.
Table 50. Biorefinery feedstocks.
Table 51. Feedstock conversion pathways.
Table 52. First-Generation Feedstocks.
Table 53. Lignocellulosic ethanol plants and capacities.
Table 54. Comparison of pulping and biorefinery lignins.
Table 55. Commercial and pre-commercial biorefinery lignin production facilities and processes
Table 56. Operating and planned lignocellulosic biorefineries and industrial flue gas-to-ethanol.
Table 57. Properties of microalgae and macroalgae.
Table 58. Yield of algae and other biodiesel crops.
Table 59. Range of biomass cost by feedstock type.
Table 60. Processes in bioethanol production.
Table 61. Microorganisms used in CBP for ethanol production from biomass lignocellulosic.
Table 62. Biodiesel by generation.
Table 63. Biodiesel production techniques.
Table 64. Biofuel production cost from the biomass pyrolysis process.
Table 65. Biogas feedstocks.
Table 66. Advantages and disadvantages of Bio-aviation fuel.
Table 67. Production pathways for Bio-aviation fuel.
Table 68. Current and announced Bio-aviation fuel facilities and capacities.
Table 69. Algae-derived biofuel producers.
Table 70. Markets and applications for biohydrogen.
Table 71. Comparison of different Bio-H2 production pathways.
Table 72. Properties of petrol and biobutanol.
Table 73. Comparison of biogas, biomethane and natural gas.
Table 74. Biobased chemicals that can be produced using synthetic biology approaches.
Table 75. Applications of bio-based caprolactam.
Table 76. Applications of bio-based acrylic acid.
Table 77. Applications of bio-based 1,4-Butanediol (BDO).
Table 78. Applications of bio-based ethylene.
Table 79. Biobased feedstock sources for 3-HP.
Table 80. Applications of 3-HP.
Table 81. Applications of bio-based 1,3-Propanediol (1,3-PDO).
Table 82. Biobased feedstock sources for itaconic acid.
Table 83. Applications of bio-based itaconic acid.
Table 84. Biobased feedstocks that can be used to produce 1,5-diaminopentane (DA5).
Table 85. Applications of DN5.
Table 86. Applications of bio-based Tetrahydrofuran (THF).
Table 87. Markets and applications for malonic acid.
Table 88. Biobased feedstock sources for MEG.
Table 89. Applications of bio-based MEG.
Table 90. Applications of bio-based propylene.
Table 91. Biobased feedstock sources for Succinic acid.
Table 92. Applications of succinic acid.
Table 93. Bioplastics and bioplastic precursors synthesized via white biotechnology processes.
Table 94. Polylactic acid (PLA) market analysis-manufacture, advantages, disadvantages and applications.
Table 95. PLA producers and production capacities.
Table 96. Types of PHAs and properties.
Table 97. Comparison of the physical properties of different PHAs with conventional petroleum-based polymers.
Table 98. Polyhydroxyalkanoate (PHA) extraction methods.
Table 99. Commercially available PHAs.
Table 100. Types of protein based-bioplastics, applications and companies.
Table 101. Applications of white biotechnology in bioremediation and environmental remediation.
Table 102. Companies developing fermentation-derived food.
Table 103. Biofertilizer companies.
Table 104. Biopesticides companies.
Table 105. Biostimulants companies.
Table 106. Crop biotechnology companies.
Table 107. Types of sustainable alternative leathers.
Table 108. Properties of bio-based leathers.
Table 109. Comparison with conventional leathers.
Table 110. Price of commercially available sustainable alternative leather products.
Table 111. Comparative analysis of sustainable alternative leathers.
Table 112. Key processing steps involved in transforming plant fibers into leather materials.
Table 113. Current and emerging plant-based leather products.
Table 114. Companies developing plant-based leather products.
Table 115. Overview of mycelium-description, properties, drawbacks and applications.
Table 116. Companies developing mycelium-based leather products.
Table 117. Types of microbial-derived leather alternative.
Table 118. Companies developing microbial leather products.
Table 119. Companies developing plant-based leather products.
Table 120. Types of protein-based leather alternatives.
Table 121. Companies developing protein based leather.
Table 122. Applications, advantages and disadvantages of PHAs in packaging.
Table 123. Types of protein based-bioplastics, applications and companies.
Table 124. Overview of alginate-description, properties, application and market size.
Table 125. Pharmaceutical applications of synthetic biology.
Table 126. Companies involved in synthetic biology for gene therapy and regenerative medicine
Table 127. Companies involved in synthetic biology for vaccine production.
Table 128. Companies involved in synthetic biology for personalized medicine.
Table 129. Synthetic biology companies in healthcare and pharmaceuticals.
Table 130. Applications of biotechnology in the cosmetics industry.
Table 131. Sustainable biomanufacturing of surfactants and detergents.
Table 132. Global Revenues for Synthetic Biology by Technology, 2019-2037 (Billion USD).
Table 133. Global Revenues for Synthetic Biology by Product Type, 2019-2037 (Billion USD).
Table 134. Global revenues for synthetic biology, by market, 2019-2037 (Billion USD).
Table 135. Global revenues for synthetic biology, by region, 2019-2037 (Billion USD).
Table 136. Scale-up transition points and typical failure modes.
Table 137. Glossary of Terms.
LIST OF FIGURES
Figure 1. Global Revenues for Synthetic Biology by Technology, 2019-2037 (Billion USD).
Figure 2. Global Revenues for Synthetic Biology by Product Type, 2019-2037 (Billion USD).
Figure 3. Global revenues for synthetic biology, by market, 2019-2037 (Billion USD).
Figure 4. Global revenues for synthetic biology, by region, 2019-2037 (Billion USD).
Figure 5. Industrial biotechnology value chain.
Figure 6. Cell-free and cell-based protein synthesis systems.
Figure 7. CRISPR/Cas9 & Targeted Genome Editing.
Figure 8. Genetic Circuit-Assisted Smart Microbial Engineering.
Figure 9. Microbial Chassis Development for Natural Product Biosynthesis.
Figure 10. LanzaTech gas-fermentation process.
Figure 11. Schematic of biological CO2 conversion into e-fuels.
Figure 12. Overview of biogas utilization.
Figure 13. Biogas and biomethane pathways.
Figure 14. Schematic overview of anaerobic digestion process for biomethane production.
Figure 15. BLOOM masterbatch from Algix.
Figure 16. SWOT analysis: synthetic biology.
Figure 17. Schematic of a biorefinery for production of carriers and chemicals.
Figure 18. Overview of biogas utilization.
Figure 19. Biogas and biomethane pathways.
Figure 20. Schematic overview of anaerobic digestion process for biomethane production.
Figure 21. Algal biomass conversion process for biofuel production.
Figure 22. Pathways for algal biomass conversion to biofuels.
Figure 23. Biobutanol production route.
Figure 24. Renewable Methanol Production Processes from Different Feedstocks.
Figure 25. Production of biomethane through anaerobic digestion and upgrading.
Figure 26. Production of biomethane through biomass gasification and methanation.
Figure 27. Production of biomethane through the Power to methane process.
Figure 28. Overview of Toray process.
Figure 29. Bacterial nanocellulose shapes
Figure 30. PHA family.
Figure 31. AlgiKicks sneaker, made with the Algiknit biopolymer gel.
Figure 32. Conceptual landscape of next-gen leather materials.
Figure 33. Hermes bag made of MycoWorks' mycelium leather.
Figure 34. Ganni blazer made from bacterial cellulose.
Figure 35. Bou Bag by GANNI and Modern Synthesis.
Figure 36. Paper cups lined with home-compostable PHA.
Figure 37. Amorphous PHA Cosmetics Jar.
Figure 38. Types of bio-based materials used for antimicrobial food packaging application.
Figure 39. Self-healing bacteria crack filler for concrete.
Figure 40. BioMason cement.
Figure 41. Microalgae based biocement masonry bloc.
Figure 42. Typical structure of mycelium-based foam.
Figure 43. Commercial mycelium composite construction materials.
Figure 44. Global Revenues for Synthetic Biology by Technology, 2019-2037 (Billion USD).
Figure 45. Global Revenues for Synthetic Biology by Product Type, 2019-2037 (Billion USD).
Figure 46. Global revenues for synthetic biology, by market, 2019-2037 (Billion USD).
Figure 47. Global revenues for synthetic biology, by region, 2019-2037 (Billion USD).
Figure 48. Jelly-like seaweed-based nanocellulose hydrogel.
Figure 49. Algiknit yarn.
Figure 50. ALGIECEL PhotoBioReactor.
Figure 51. BIOLO e-commerce mailer bag made from PHA.
Figure 52. Domsjo process.
Figure 53. Mushroom leather.
Figure 54. PHA production process.
Figure 55. Light Bio Bioluminescent plants.
Figure 56. Lignin gel.
Figure 57. BioFlex process.
Figure 58. TransLeather.
Figure 59. Reishi.
Figure 60. Compostable water pod.
Figure 61. Precision Photosynthesis technology.
Figure 62. Enfinity cellulosic ethanol technology process.
Figure 63. Fabric consisting of 70 per cent wool and 30 per cent Qmilk.
Figure 64. Lyocell process.
Figure 65. Spider silk production.
Figure 66. Corbion FDCA production process.
Figure 67. UPM biorefinery process.
Figure 68. The Proesa Process.
A selection of companies mentioned in this report includes, but is not limited to:
- Aanika Biosciences Aemetis AEP Polymers Afyren AgBiome AgriSea NZ Seaweed Agrivida Ainnocence AIO AI Proteins Algal Bio Algenol AlgiKnit Algiecel Alpha Biofuels Allonnia Allozymes Alt.Leather Alto Neuroscience Amano Enzyme AmphiStar Amply Discovery AMSilk Amyris Andes Ag Ansa Biotechnologies Antheia Apeel Sciences Aralez Bio Arctic Biomaterials Ardra Bio Arkeon Arsenale Bioyards Arzeda Asimov Atantares Autolus AVA Biochem Avantium Azolla Axcelon Biopolymers Basecamp Research BBCA Biochemical & GALACTIC Lactic Acid Benefuel BioBetter Bioextrax Bio Fab NZ Biokemik BIOLO Biomason Biomemory Bioplastech BioSmart Nano Biotic Circular Technologies Biosyntia Biotecam Bioweg bit.bio Bloom Biorenewables BluCon Biotech Blue BioFuels Bluepha Bon Vivant Bolt Threads Bosk Bioproducts Bowil Biotech Braskem Brightseed Bucha Bio C1 Green Chemicals C16 Biosciences CABIO Biotech California Cultured Calysta Cambrium Camena Bioscience Capra Biosciences Carbios Cargill Calyxt Cascade Biocatalysts Cass Materials Catalyxx Cathy Biotech Cauldron Ferm Cemvita Factory ChainCraft Checkerspot Chitose Bio Evolution CinderBio Circe CJ Biomaterials Clean Food Group Codagenix Codexis Colossal Biosciences Colipi Colorifix Conagen Constructive Bio Cysbio Danimer Scientific Debut Biotechnology Deep Branch Biotechnology Demetrix Dispersa DMC Biotechnologies DNA Script Domsjo Fabriker DoriNano DuPont Earli Ecovative Design Eco Fuel Technology Eden Brew EggPlant Eligo Bioscience Elo Life Systems Emerging Fuels Technology Enduro Genetics EnginZyme Eni EnPlusOne Biosciences Enzymaster Enzymit Erebagen Esphera SynBio Euglena Eversyn Evozyne FabricNano Fermentalg Forage Evolution and more......
For more information about this report visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment